Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Income towards Parent Company: 2021-2025

Historic Income towards Parent Company for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$196,000.

  • Immunocore Holdings' Income towards Parent Company fell 102.24% to -$196,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 37.83%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
  • Latest data reveals that Immunocore Holdings reported Income towards Parent Company of -$196,000 as of Q3 2025, which was up 98.10% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Income towards Parent Company ranged from a high of $8.7 million in Q3 2024 and a low of -$52.6 million during Q4 2021.
  • Moreover, its 3-year median value for Income towards Parent Company was -$11.6 million (2024), whereas its average is -$10.2 million.
  • As far as peak fluctuations go, Immunocore Holdings' Income towards Parent Company spiked by 864.24% in 2024, and later crashed by 102.24% in 2025.
  • Immunocore Holdings' Income towards Parent Company (Quarterly) stood at -$52.6 million in 2021, then reached -$19.7 million in 2023, then fell by 20.48% to -$23.8 million in 2024, then crashed by 102.24% to -$196,000 in 2025.
  • Its last three reported values are -$196,000 in Q3 2025, -$10.3 million for Q2 2025, and $5.0 million during Q1 2025.